BACKGROUND: Several case-control studies have found an association between chronic beryllium disease (CBD) and HLA-DPB1 gene variants. However, the relationship between HLA-DPB1 and beryllium sensitization, and whether the presence of one or two HLA-DPB1(Glu69) alleles is differentially associated with CBD and beryllium sensitization have not been completely resolved. METHODS: Restriction fragment length polymorphism (RFLP) analysis was used to address these questions in a large population-based cohort consisting of 884 beryllium workers (90 with CBD, 64 beryllium sensitized). RESULTS: HLA-DPB1(Glu69) was associated with both CBD (OR = 9.4; 95% CI = 5.4, 16.6) and sensitization (OR = 3.3, 95% CI = 1.9, 5.9). Further, workers with CBD and sensitization were more likely to be homozygous HLA-DPB1(Glu69) compared to workers without disease or sensitization (P < 0.001). CONCLUSIONS: Follow-up of this cohort, scrutiny of HLA-DPB1 haplotypes, and evaluation of gene-environment and gene-gene interactions will be important for fully understanding the immunogenetic nature of this occupational disease.
BACKGROUND: Several case-control studies have found an association between chronic beryllium disease (CBD) and HLA-DPB1 gene variants. However, the relationship between HLA-DPB1 and beryllium sensitization, and whether the presence of one or two HLA-DPB1(Glu69) alleles is differentially associated with CBD and beryllium sensitization have not been completely resolved. METHODS: Restriction fragment length polymorphism (RFLP) analysis was used to address these questions in a large population-based cohort consisting of 884 beryllium workers (90 with CBD, 64 beryllium sensitized). RESULTS:HLA-DPB1(Glu69) was associated with both CBD (OR = 9.4; 95% CI = 5.4, 16.6) and sensitization (OR = 3.3, 95% CI = 1.9, 5.9). Further, workers with CBD and sensitization were more likely to be homozygous HLA-DPB1(Glu69) compared to workers without disease or sensitization (P < 0.001). CONCLUSIONS: Follow-up of this cohort, scrutiny of HLA-DPB1 haplotypes, and evaluation of gene-environment and gene-gene interactions will be important for fully understanding the immunogenetic nature of this occupational disease.
Authors: Kristin J Cummings; Doug O Johns; Jacek M Mazurek; Frank J Hearl; David N Weissman Journal: Arch Environ Occup Health Date: 2018-12-02 Impact factor: 1.663
Authors: Shaodong Dai; Guinevere A Murphy; Frances Crawford; Douglas G Mack; Michael T Falta; Philippa Marrack; John W Kappler; Andrew P Fontenot Journal: Proc Natl Acad Sci U S A Date: 2010-03-31 Impact factor: 11.205
Authors: Kathleen Kreiss; Ethan D Fechter-Leggett; Erin C McCanlies; Christine R Schuler; Ainsley Weston Journal: J Occup Environ Med Date: 2016-09 Impact factor: 2.162
Authors: Hiroe Sato; Felix A Woodhead; Tariq Ahmad; Jan C Grutters; Paolo Spagnolo; Jules M M van den Bosch; Lisa A Maier; Lee S Newman; Sonoko Nagai; Takateru Izumi; Athol U Wells; Roland M du Bois; Kenneth I Welsh Journal: Hum Mol Genet Date: 2010-08-03 Impact factor: 6.150
Authors: James A Snyder; Eugene Demchuk; Erin C McCanlies; Christine R Schuler; Kathleen Kreiss; Michael E Andrew; Bonnie L Frye; James S Ensey; Marcia L Stanton; Ainsley Weston Journal: J R Soc Interface Date: 2008-07-06 Impact factor: 4.118
Authors: Kristin J Cummings; Aleksandr B Stefaniak; M Abbas Virji; Kathleen Kreiss Journal: Environ Health Perspect Date: 2009-04-28 Impact factor: 9.031